DCM (DCM)

Score breakdown: P/E: 1/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Very low debt/equity of 0.03 minimizes balance-sheet risk.
• Promoter holding of 49.88% aligns ownership with minority investors.
• Reported ROCE of 78.63% indicates capital-efficient operations, if sustained.
• Sales still grew 1.96%, providing a base for a potential turnaround.

Concerns

• Negative ROE of -3.24% and profit growth of -101.46% show the company is barely breaking even.
• P/B of 41.08 against book value of ₹1.92 leaves almost no asset-based margin of safety.
• Zero dividend and a Piotroski F-Score of 4/9 suggest weak overall financial health.
• P/E of 27.28 and PEG of 13.92 are unreliable given negligible earnings.

AI Analysis

When I look at DCM, I see a small IT-enabled services company with a market cap of just ₹145 Cr and a price of ₹78.88. In Graham's language, price is what you pay and value is what you get. Here, the price demands close scrutiny. The company carries very little debt—Debt/Equity of 0.03—so it is not at risk of financial distress. Promoters hold 49.88%, and that generally aligns their interests with mine. The reported ROCE of 78.63% looks impressive, but I am cautious: with book value of only ₹1.92, a small amount of capital can produce a high ROCE that may not be sustainable or economically meaningful. The earnings quality troubles me. ROE is negative at -3.24%, and profit growth has collapsed by 101.46%. The latest quarter shows sales of ₹18 Cr but net profit of roughly ₹-0 Cr—the company is barely breaking even. A P/E of 27.28 on such a fragile earnings base is unreliable, and a P/B of 41.08 gives me no margin of safety from assets. Sales growth of just 1.96% is hardly a sign of momentum, and there is no dividend to compensate while I wait. Piotroski F-Score of 4/9 says weak overall fundamentals. This is not a compounding stalwart or a fast grower. It is a possible turnaround situation, but only if management can convert an apparently efficient operating structure into real, sustained net profits. I prefer my investments to be obvious, and this one is not. I need to see actual earnings recovery before I part with my money. I would watch quarterly profit margins closely, and any sign of revenue acceleration. Until ROE turns positive and profits remain above zero consistently, DCM remains a high-risk speculation disguised as a cheap small-cap.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer